SARS-CoV-2 Trimeric Spike C.37 (lambda)


Datasheet as
Name SARS-CoV-2 Trimeric Spike C.37 (lambda)
Description Protein contains amino acids 14-1211 and following mutations: G75V, T76I, del 246-252, L452Q, F490S, D614G, T859N. Plus two extra amino acids (AS) in N-terminus, trimerization domain and His-6 tag at C-terminus, GS linker between protein and trimerization domain and GSG linker between trimerization domain and His-tag. Furin cleavage (RRAR) site between Spike S1 and S2 is mutated (GSAS).
Uniprot ID P0DTC2
Source Human
MW 408.032 kDa
Host CHO-based cell line (expressed by QMCF Technology)
Purification Purified by Ni-affinity chromatography and gel-filtration from serum-free CHO growth media, sterile filtrated
Purity >95%
Concentration 1 mg/ml
Buffer PBS pH 7.4
Endotoxine NA
QC SDS-PAGE, analytical SEC, Octet binding
Shipping Shipped on dry ice.
Storage Store at -20 °C to -70 °C long term. Avoid multiple freeze-thaw cycles.
Buy now

€750 / 100µg
€1450 / 500µg
€1950 / 1000µg

Figure 1.  Simply Blue stained SDS-PAGE analysis of SARS-CoV-2 Trimeric Spike C.37 . 4-12% gradient gel is used for analysis. Lane 1. 0.8 µg SARS-CoV-2 Trimeric Spike C.37 (-DTT) Lane 2. Protein marker (Smobio) Lane 3. 0.8 µg SARS-CoV-2 Trimeric Spike C.37 (+DTT)
Figure 2. Octet Red96e analysis of SARS-CoV-2 Trimeric Spike C.37 binding to human ACE2 receptor.